Karyopharm Therapeutics Overview
Karyopharm Therapeutics Discounted Cash Flow
DCF Analysis for KPTI.
Get informed when a big investor buys or sells
+ FollowFair Value
$1.36
Current Fair Value
$1.36
↓ 84.9% Downside
Overvalued by 84.9% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison